Japan's cannabis law reforms mark a significant shift in the country's regulatory stance on the plant. The recent amendments to the Cannabis Control Act and the Narcotics and Psychotropics Control Act permit the use of cannabis-derived pharmaceuticals for medical purposes and introduce a tiered licensing system for cannabis cultivation. While these reforms open up new opportunities for the industry, strict THC limits on CBD products present challenges for producers and importers. As Japan embraces the therapeutic potential of cannabis and navigates the complexities of its regulatory landscape, the future of the cannabis industry in the country remains promising.

For further insights, please read the attached full report.